{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:37:34Z","timestamp":1791571054277,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C2102308"],"award-info":[{"award-number":["2020R1A2C2102308"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM5392212"],"award-info":[{"award-number":["KGM5392212"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims\/hypothesis<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) associated with type 2 diabetes may more easily progress towards severe forms of non-alcoholic steatohepatitis (NASH) and cirrhosis. Although the Wnt effector transcription factor 7-like 2 (TCF7L2) is closely associated with type 2 diabetes risk, the role of TCF7L2 in NAFLD development remains unclear. Here, we investigated how changes in TCF7L2 expression in the liver affects hepatic lipid metabolism based on the major risk factors of NAFLD development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      was selectively ablated in the liver of C57BL\/6N mice by inducing the albumin (\n                      <jats:italic>Alb<\/jats:italic>\n                      ) promoter to recombine\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      alleles floxed at exon 5 (liver-specific\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      -knockout [KO] mice:\n                      <jats:italic>Alb-Cre;Tcf7l2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>f\/f<\/jats:italic>\n                      <\/jats:sup>\n                      ).\n                      <jats:italic>Alb-Cre;Tcf7l2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>f\/f<\/jats:italic>\n                      <\/jats:sup>\n                      and their wild-type (\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>f\/f<\/jats:italic>\n                      <\/jats:sup>\n                      ) littermates were fed a high-fat diet (HFD) or a high-carbohydrate diet (HCD) for 22 weeks to reproduce NAFLD\/NASH. Mice were refed a standard chow diet or an HCD to stimulate de novo lipogenesis (DNL) or fed an HFD to provide exogenous fatty acids. We analysed glucose and insulin sensitivity, metabolic respiration, mRNA expression profiles, hepatic triglyceride (TG), hepatic DNL, selected hepatic metabolites, selected plasma metabolites and liver histology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Alb-Cre;Tcf7l2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>f\/f<\/jats:italic>\n                      <\/jats:sup>\n                      essentially exhibited increased lipogenic genes, but there were no changes in hepatic lipid content in mice fed a normal chow diet. However, following 22 weeks of diet-induced NAFLD\/NASH conditions, liver steatosis was exacerbated owing to preferential metabolism of carbohydrate over fat. Indeed, hepatic\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      deficiency enhanced liver lipid content in a manner that was dependent on the duration and amount of exposure to carbohydrates, owing to cell-autonomous increases in hepatic DNL. Mechanistically, TCF7L2 regulated the transcriptional activity of\n                      <jats:italic>Mlxipl<\/jats:italic>\n                      (also known as\n                      <jats:italic>ChREBP<\/jats:italic>\n                      ) by modulating\n                      <jats:italic>O<\/jats:italic>\n                      -GlcNAcylation and protein content of carbohydrate response element binding protein (ChREBP), and targeted\n                      <jats:italic>Srebf1<\/jats:italic>\n                      (also called\n                      <jats:italic>SREBP1<\/jats:italic>\n                      ) via miRNA (miR)-33-5p in hepatocytes. Eventually, restoring\n                      <jats:italic>TCF7L2<\/jats:italic>\n                      expression at the physiological level in the liver of\n                      <jats:italic>Alb-Cre;Tcf7l2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>f\/f<\/jats:italic>\n                      <\/jats:sup>\n                      mice alleviated liver steatosis without altering body composition under both acute and chronic HCD conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>\n                      In mice, loss of hepatic\n                      <jats:italic>Tcf7l2<\/jats:italic>\n                      contributes to liver steatosis by inducing preferential metabolism of carbohydrates via DNL activation. Therefore, TCF7L2 could be a promising regulator of the NAFLD associated with high-carbohydrate diets and diabetes since TCF7L2 deficiency may lead to development of NAFLD by promoting utilisation of excess glucose pools through activating DNL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data availability<\/jats:title>\n                    <jats:p>\n                      RNA-sequencing data have been deposited into the NCBI GEO under the accession number GSE162449 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE162449\">www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE162449<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-023-05878-8","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T09:37:34Z","timestamp":1676021854000},"page":"931-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6535-7583","authenticated-orcid":false,"given":"Da Som","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-767X","authenticated-orcid":false,"given":"Tae Hyeon","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5596-4320","authenticated-orcid":false,"given":"Hyunmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-6138","authenticated-orcid":false,"given":"Eunsun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-3002","authenticated-orcid":false,"given":"Gyeonghun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-9587","authenticated-orcid":false,"given":"Seung Yeon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-6793","authenticated-orcid":false,"given":"Jun Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-7077","authenticated-orcid":false,"given":"Hye Jin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-4603","authenticated-orcid":false,"given":"Jaeeun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-0003","authenticated-orcid":false,"given":"Eun-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-7216","authenticated-orcid":false,"given":"Baek-Soo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-7876","authenticated-orcid":false,"given":"Dai Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-4942","authenticated-orcid":false,"given":"Yong-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-5898","authenticated-orcid":false,"given":"Tae-Su","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6944-2718","authenticated-orcid":false,"given":"Keun","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-5746","authenticated-orcid":false,"given":"Chul-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4999-1613","authenticated-orcid":false,"given":"Dae-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-0333","authenticated-orcid":false,"given":"Won Kon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4677-1786","authenticated-orcid":false,"given":"Jun Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-2879","authenticated-orcid":false,"given":"Seung-Hoi","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-6958","authenticated-orcid":false,"given":"Je Kyung","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1507-3267","authenticated-orcid":false,"given":"Sang Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-1349","authenticated-orcid":false,"given":"Hail","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-2556","authenticated-orcid":false,"given":"Kwang-Hee","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-7202","authenticated-orcid":false,"given":"Kyoung-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"3","key":"5878_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/er.2015-1146","volume":"37","author":"T Jin","year":"2016","unstructured":"Jin T (2016) Current understanding on role of the Wnt signalling pathway effector TCF7L2 in glucose homeostasis. Endocr Rev 37(3):254\u2013277. https:\/\/doi.org\/10.1210\/er.2015-1146","journal-title":"Endocr Rev"},{"issue":"5","key":"5878_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.molmet.2015.03.002","volume":"4","author":"A Migliorini","year":"2015","unstructured":"Migliorini A, Lickert H (2015) Beyond association: a functional role for Tcf7l2 in \u03b2-cell development. Mol Metab 4(5):365\u2013366. https:\/\/doi.org\/10.1016\/j.molmet.2015.03.002","journal-title":"Mol Metab"},{"key":"5878_CR3","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/hmg\/ddp178","volume":"18","author":"L Shu","year":"2009","unstructured":"Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 18:2388\u20132399. https:\/\/doi.org\/10.1093\/hmg\/ddp178","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5878_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00125-020-05292-4","volume":"64","author":"MS Nguyen-Tu","year":"2021","unstructured":"Nguyen-Tu MS, Martinez-Sanchez A, Leclerc I, Rutter GA, da Silva Xavier G (2021) Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice. Diabetologia 64(1):129\u2013141. https:\/\/doi.org\/10.1007\/s00125-020-05292-4","journal-title":"Diabetologia"},{"key":"5878_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molmet.2019.03.003","volume":"24","author":"G Geoghegan","year":"2019","unstructured":"Geoghegan G, Simcox J, Seldin MM et al (2019) Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism. Mol Metab 24:44\u201363. https:\/\/doi.org\/10.1016\/j.molmet.2019.03.003","journal-title":"Mol Metab"},{"issue":"9","key":"5878_CR6","doi-asserted-by":"publisher","first-page":"E1166","DOI":"10.1152\/ajpendo.00249.2012","volume":"303","author":"W Ip","year":"2012","unstructured":"Ip W, Shao W, Chiang YT, Jin T (2012) The Wnt signalling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 303(9):E1166\u2013E1176. https:\/\/doi.org\/10.1152\/ajpendo.00249.2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"5878_CR7","doi-asserted-by":"publisher","first-page":"e1002986","DOI":"10.1371\/journal.pgen.1002986","volume":"8","author":"KJ Oh","year":"2012","unstructured":"Oh KJ, Park J, Kim SS, Oh H, Choi CS, Koo SH (2012) TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in liver. PLoS Genet 8(9):e1002986. https:\/\/doi.org\/10.1371\/journal.pgen.1002986","journal-title":"PLoS Genet"},{"issue":"6","key":"5878_CR8","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2337\/db14-1329","volume":"64","author":"W Ip","year":"2015","unstructured":"Ip W, Shao W, Song Z, Chen Z, Wheeler MB, Jin T (2015) Liver-specific expression of dominant-negative transcription factor 7-like 2 causes progressive impairment in glucose homeostasis. Diabetes 64(6):1923\u20131932. https:\/\/doi.org\/10.2337\/db14-1329","journal-title":"Diabetes"},{"issue":"3","key":"5878_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa062418","volume":"355","author":"JC Florez","year":"2006","unstructured":"Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355(3):241\u2013250. https:\/\/doi.org\/10.1056\/NEJMoa062418","journal-title":"N Engl J Med"},{"issue":"3","key":"5878_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng1732","volume":"38","author":"SF Grant","year":"2006","unstructured":"Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38(3):320\u2013323. https:\/\/doi.org\/10.1038\/ng1732","journal-title":"Nat Genet"},{"issue":"6","key":"5878_CR11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2337\/db20-0573","volume":"70","author":"L Del Bosque-Plata","year":"2021","unstructured":"Del Bosque-Plata L, Mart\u00ednez-Mart\u00ednez E, Espinoza-Camacho M\u00c1, Gragnoli C (2021) The role of TCF7L2 in type 2 diabetes. Diabetes 70(6):1220\u20131228. https:\/\/doi.org\/10.2337\/db20-0573","journal-title":"Diabetes"},{"issue":"2","key":"5878_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/hep.22659","volume":"49","author":"G Musso","year":"2009","unstructured":"Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M (2009) Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 49(2):426\u2013435. https:\/\/doi.org\/10.1002\/hep.22659","journal-title":"Hepatology"},{"issue":"3","key":"5878_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2337\/dc16-1787","volume":"40","author":"F Bril","year":"2017","unstructured":"Bril F, Cusi K (2017) Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care 40(3):419\u2013430. https:\/\/doi.org\/10.2337\/dc16-1787","journal-title":"Diabetes Care"},{"key":"5878_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fphar.2019.00877","volume":"10","author":"MF Xia","year":"2019","unstructured":"Xia MF, Bian H, Gao X (2019) NAFLD and diabetes: two sides of the same coin? Rationale for gene-based personalized NAFLD treatment. Front Pharmacol 10:877. https:\/\/doi.org\/10.3389\/fphar.2019.00877","journal-title":"Front Pharmacol"},{"issue":"9","key":"5878_CR15","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/ijms22094495","volume":"22","author":"H Kim","year":"2021","unstructured":"Kim H, Lee DS, An TH et al (2021) Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC. Int J Mol Sci 22(9):4495. https:\/\/doi.org\/10.3390\/ijms22094495","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5878_CR16","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.3390\/nu7064995","volume":"7","author":"E Fabbrini","year":"2015","unstructured":"Fabbrini E, Magkos F (2015) Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 7(6):4995\u20135019. https:\/\/doi.org\/10.3390\/nu7064995","journal-title":"Nutrients"},{"issue":"5","key":"5878_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s1262-3636(07)70061-7","volume":"29","author":"F Diraison","year":"2003","unstructured":"Diraison F, Moulin P, Beylot M (2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 29(5):478\u2013485. https:\/\/doi.org\/10.1016\/s1262-3636(07)70061-7","journal-title":"Diabetes Metab"},{"issue":"5","key":"5878_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343\u20131351. https:\/\/doi.org\/10.1172\/JCI23621","journal-title":"J Clin Invest"},{"issue":"5","key":"5878_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molmet.2015.03.004","volume":"4","author":"G Solinas","year":"2015","unstructured":"Solinas G, Bor\u00e9n J, Dulloo AG (2015) De novo lipogenesis in metabolic homeostasis: more friend than foe? Mol Metab 4(5):367\u2013377. https:\/\/doi.org\/10.1016\/j.molmet.2015.03.004","journal-title":"Mol Metab"},{"key":"5878_CR20","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","volume":"13","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kim G, Han DH et al (2017) Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy 13:1767\u20131781. https:\/\/doi.org\/10.1080\/15548627.2017.1356977","journal-title":"Autophagy"},{"issue":"6","key":"5878_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology"},{"issue":"7","key":"5878_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbagrm.2018.06.003","volume":"1861","author":"E Jung","year":"2018","unstructured":"Jung E, Seong Y, Jeon B, Kwon YS, Song H (2018) MicroRNAs of miR-17-92 cluster increase gene expression by targeting mRNA-destabilization pathways. Biochim Biophys Acta Gene Regul Mech 1861(7):603\u2013612. https:\/\/doi.org\/10.1016\/j.bbagrm.2018.06.003","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"9","key":"5878_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.14348\/molcells.2017.0116","volume":"40","author":"SK Byun","year":"2017","unstructured":"Byun SK, An TH, Son MJ et al (2017) HDAC11 inhibits myoblast differentiation through repression of MyoD-dependent transcription. Mol Cells 40(9):667\u2013676. https:\/\/doi.org\/10.14348\/molcells.2017.0116","journal-title":"Mol Cells"},{"issue":"1","key":"5878_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42826-020-00076-8","volume":"36","author":"AP Mishra","year":"2020","unstructured":"Mishra AP, Siva AB, Gurunathan C, Komala Y, Lakshmi BJ (2020) Impaired liver regeneration and lipid homeostasis in CCl4 treated WDR13 deficient mice. Lab Anim Res 36(1):41. https:\/\/doi.org\/10.1186\/s42826-020-00076-8","journal-title":"Lab Anim Res"},{"issue":"12","key":"5878_CR25","doi-asserted-by":"publisher","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","volume":"9","author":"W Liang","year":"2014","unstructured":"Liang W, Menke AL, Driessen A et al (2014) Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PLoS One 9(12):e115922. https:\/\/doi.org\/10.1371\/journal.pone.0115922","journal-title":"PLoS One"},{"issue":"11","key":"5878_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308. https:\/\/doi.org\/10.1038\/nprot.2013.143","journal-title":"Nat Protoc"},{"issue":"3","key":"5878_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbrc.2015.12.035","volume":"469","author":"DS Lee","year":"2016","unstructured":"Lee DS, Choi H, Han BS et al (2016) c-Jun regulates adipocyte differentiation via the KLF15-mediated mode. Biochem Biophys Res Commun 469(3):552\u2013558. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.035","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"5878_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/labinvest.2015.95","volume":"95","author":"M Miyao","year":"2015","unstructured":"Miyao M, Kotani H, Ishida T et al (2015) Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression. Lab Invest 95(10):1130\u20131144. https:\/\/doi.org\/10.1038\/labinvest.2015.95","journal-title":"Lab Invest"},{"key":"5878_CR29","doi-asserted-by":"publisher","first-page":"16867","DOI":"10.1038\/srep16867","volume":"5","author":"K Muramatsu-Kato","year":"2015","unstructured":"Muramatsu-Kato K, Itoh H, Kohmura-Kobayashi Y et al (2015) Undernourishment in utero primes hepatic steatosis in adult mice offspring on an obesogenic diet; involvement of endoplasmic reticulum stress. Sci Rep 5:16867. https:\/\/doi.org\/10.1038\/srep16867","journal-title":"Sci Rep"},{"key":"5878_CR30","doi-asserted-by":"publisher","first-page":"110782","DOI":"10.1016\/j.nut.2020.110782","volume":"75-76","author":"S Pompili","year":"2020","unstructured":"Pompili S, Vetuschi A, Gaudio E et al (2020) Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD\/NASH. Nutrition 75-76:110782. https:\/\/doi.org\/10.1016\/j.nut.2020.110782","journal-title":"Nutrition"},{"issue":"12","key":"5878_CR31","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1194\/jlr.M052308","volume":"55","author":"JA Duarte","year":"2014","unstructured":"Duarte JA, Carvalho F, Pearson M et al (2014) A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice. J Lipid Res 55(12):2541\u20132553. https:\/\/doi.org\/10.1194\/jlr.M052308","journal-title":"J Lipid Res"},{"issue":"6","key":"5878_CR32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1172\/JCI117252","volume":"93","author":"G Boden","year":"1994","unstructured":"Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93(6):2438\u20132446. https:\/\/doi.org\/10.1172\/JCI117252","journal-title":"J Clin Invest"},{"issue":"2","key":"5878_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2337\/diabetes.52.2.487","volume":"52","author":"CJ Homko","year":"2003","unstructured":"Homko CJ, Cheung P, Boden G (2003) Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 52(2):487\u2013491. https:\/\/doi.org\/10.2337\/diabetes.52.2.487","journal-title":"Diabetes"},{"issue":"2","key":"5878_CR34","doi-asserted-by":"publisher","first-page":"T61","DOI":"10.1530\/JOE-13-0397","volume":"220","author":"N Turner","year":"2014","unstructured":"Turner N, Cooney GJ, Kraegen EW, Bruce CR (2014) Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 220(2):T61\u2013T79. https:\/\/doi.org\/10.1530\/JOE-13-0397","journal-title":"J Endocrinol"},{"issue":"3","key":"5878_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","volume":"59","author":"AG Linden","year":"2018","unstructured":"Linden AG, Li S, Choi HY et al (2018) Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J Lipid Res 59(3):475\u2013487. https:\/\/doi.org\/10.1194\/jlr.M081836","journal-title":"J Lipid Res"},{"issue":"11","key":"5878_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, Viscarra J, Kim SJ, Sul HS (2015) Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol 16(11):678\u2013689. https:\/\/doi.org\/10.1038\/nrm4074","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"5878_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2017.07.004","volume":"26","author":"A Abdul-Wahed","year":"2017","unstructured":"Abdul-Wahed A, Guilmeau S, Postic C (2017) Sweet sixteenth for ChREBP: established roles and future goals. Cell Metab 26(2):324\u2013341. https:\/\/doi.org\/10.1016\/j.cmet.2017.07.004","journal-title":"Cell Metab"},{"issue":"5","key":"5878_CR38","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/db10-0452","volume":"60","author":"C Guinez","year":"2011","unstructured":"Guinez C, Filhoulaud G, Rayah-Benhamed F et al (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in liver. Diabetes 60(5):1399\u20131413. https:\/\/doi.org\/10.2337\/db10-0452","journal-title":"Diabetes"},{"key":"5878_CR39","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1038\/ncomms3883","volume":"4","author":"T Horie","year":"2013","unstructured":"Horie T, Nishino T, Baba O et al (2013) MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun 4:2883. https:\/\/doi.org\/10.1038\/ncomms3883","journal-title":"Nat Commun"},{"issue":"10","key":"5878_CR40","doi-asserted-by":"publisher","first-page":"e78040","DOI":"10.1371\/journal.pone.0078040","volume":"8","author":"Z Hu","year":"2013","unstructured":"Hu Z, Shen WJ, Cortez Y et al (2013) Hormonal regulation of microRNA expression in steroid producing cells of the ovary, testis and adrenal gland. PLoS One 8(10):e78040. https:\/\/doi.org\/10.1371\/journal.pone.0078040","journal-title":"PLoS One"},{"key":"5878_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biopha.2016.01.022","volume":"78","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang J, He J, Zhou W, Xiang G, Xu R (2016) MicroRNA-132 cause apoptosis of glioma cells through blockade of the SREBP-1c metabolic pathway related to SIRT1. Biomed Pharmacother 78:177\u2013184. https:\/\/doi.org\/10.1016\/j.biopha.2016.01.022","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"5878_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7150\/ijbs.4568","volume":"8","author":"H Yang","year":"2012","unstructured":"Yang H, Li Q, Lee JH, Shu Y (2012) Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice. Int J Biol Sci 8(6):791\u2013801. https:\/\/doi.org\/10.7150\/ijbs.4568","journal-title":"Int J Biol Sci"},{"issue":"7","key":"5878_CR43","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.cell.2012.10.053","volume":"151","author":"SF Boj","year":"2012","unstructured":"Boj SF, van Es JH, Huch M et al (2012) Diabetes risk gene and Wnt effector Tcf7l2\/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151(7):1595\u20131607. https:\/\/doi.org\/10.1016\/j.cell.2012.10.053","journal-title":"Cell"},{"issue":"10","key":"5878_CR44","doi-asserted-by":"publisher","first-page":"e3000444","DOI":"10.1371\/journal.pbio.3000444","volume":"17","author":"L Tian","year":"2019","unstructured":"Tian L, Shao W, Ip W, Song Z, Badakhshi Y, Jin T (2019) The developmental Wnt signalling pathway effector \u03b2-catenin\/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism. PLoS Biol 17(10):e3000444. https:\/\/doi.org\/10.1371\/journal.pbio.3000444","journal-title":"PLoS Biol"},{"issue":"14","key":"5878_CR45","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1113\/JP277767","volume":"597","author":"A Hengist","year":"2019","unstructured":"Hengist A, Koumanov F, Gonzalez JT (2019) Fructose and metabolic health: governed by hepatic glycogen status? J Physiol 597(14):3573\u20133585. https:\/\/doi.org\/10.1113\/JP277767","journal-title":"J Physiol"},{"issue":"Suppl","key":"5878_CR46","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ Wakil","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50(Suppl):S138\u2013S143. https:\/\/doi.org\/10.1194\/jlr.R800079-JLR200","journal-title":"J Lipid Res"},{"issue":"3","key":"5878_CR47","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00125-013-3131-6","volume":"57","author":"I Takamoto","year":"2014","unstructured":"Takamoto I, Kubota N, Nakaya K et al (2014) TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Diabetologia 57(3):542\u2013553. https:\/\/doi.org\/10.1007\/s00125-013-3131-6","journal-title":"Diabetologia"},{"issue":"2","key":"5878_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.molcel.2019.05.019","volume":"75","author":"EA Lane","year":"2019","unstructured":"Lane EA, Choi DW, Garcia-Haro L et al (2019) HCF-1 regulates de novo lipogenesis through a nutrient-sensitive complex with ChREBP. Mol Cell 75(2):357\u2013371. https:\/\/doi.org\/10.1016\/j.molcel.2019.05.019","journal-title":"Mol Cell"},{"issue":"2","key":"5878_CR49","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1039\/d0fo02286a","volume":"12","author":"JH Pan","year":"2021","unstructured":"Pan JH, Cha H, Tang J et al (2021) The role of microRNA-33 as a key regulator in hepatic lipogenesis signalling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL\/6N mice. Food Funct 12(2):656\u2013667. https:\/\/doi.org\/10.1039\/d0fo02286a","journal-title":"Food Funct"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05878-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-05878-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05878-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T09:03:52Z","timestamp":1679562232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-05878-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5878"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-05878-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}